These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20561458)

  • 1. [Research advance on fludarabine resistance mechanisms in chronic lymphocytic leukemia cells].
    Yao L; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):821-4. PubMed ID: 20561458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues.
    Pettitt AR; Sherrington PD; Cawley JC
    Cancer Res; 2000 Aug; 60(15):4187-93. PubMed ID: 10945628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
    Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT
    Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.
    Moussay E; Palissot V; Vallar L; Poirel HA; Wenner T; El Khoury V; Aouali N; Van Moer K; Leners B; Bernardin F; Muller A; Cornillet-Lefebvre P; Delmer A; Duhem C; Ries F; van Dyck E; Berchem G
    Mol Cancer; 2010 May; 9():115. PubMed ID: 20487546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.
    Molina-Arcas M; Marcé S; Villamor N; Huber-Ruano I; Casado FJ; Bellosillo B; Montserrat E; Gil J; Colomer D; Pastor-Anglada M
    Leukemia; 2005 Jan; 19(1):64-8. PubMed ID: 15510196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia.
    Pandzic T; Larsson J; He L; Kundu S; Ban K; Akhtar-Ali M; Hellström AR; Schuh A; Clifford R; Blakemore SJ; Strefford JC; Baumann T; Lopez-Guillermo A; Campo E; Ljungström V; Mansouri L; Rosenquist R; Sjöblom T; Hellström M
    Clin Cancer Res; 2016 Dec; 22(24):6217-6227. PubMed ID: 26957556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
    de la Fuente MT; Casanova B; Moyano JV; Garcia-Gila M; Sanz L; Garcia-Marco J; Silva A; Garcia-Pardo A
    J Leukoc Biol; 2002 Mar; 71(3):495-502. PubMed ID: 11867687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide synergistically potentiates the cytotoxic effect of fludarabine in chronic lymphocytic leukemia cells by further inactivating the Akt and ERK signaling pathways.
    Lozano-Santos C; Amigo-Jiménez I; Nova-Gurumeta S; Pérez-Sanz N; García-Pardo A; García-Marco JA
    Biochem Biophys Res Commun; 2015 May; 461(2):243-8. PubMed ID: 25869069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole-3-Carbinol Synergizes with and Restores Fludarabine Sensitivity in Chronic Lymphocytic Leukemia Cells Irrespective of p53 Activity and Treatment Resistances.
    Perez-Chacon G; Martinez-Laperche C; Rebolleda N; Somovilla-Crespo B; Muñoz-Calleja C; Buño I; Zapata JM
    Clin Cancer Res; 2016 Jan; 22(1):134-45. PubMed ID: 26324744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of relapsed refractory chronic lymphocytic leukemia.
    Brown JR
    Hematology Am Soc Hematol Educ Program; 2011; 2011():110-8. PubMed ID: 22160021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia.
    Molina-Arcas M; Bellosillo B; Casado FJ; Montserrat E; Gil J; Colomer D; Pastor-Anglada M
    Blood; 2003 Mar; 101(6):2328-34. PubMed ID: 12411296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
    Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
    Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.
    López-Guerra M; Trigueros-Motos L; Molina-Arcas M; Villamor N; Casado FJ; Montserrat E; Campo E; Colomer D; Pastor-Anglada M
    Haematologica; 2008 Dec; 93(12):1843-51. PubMed ID: 18945750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
    Perkins JG; Flynn JM; Howard RS; Byrd JC
    Cancer; 2002 Apr; 94(7):2033-9. PubMed ID: 11932906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of deoxycytidine kinase gene expression with fludarabine resistance in patients with chronic lymphocytic leukemia].
    Yao L; Xu W; Fan L; Miao KR; Wu YJ; Qiao C; Zhu DX; Zhu HY; Liu P; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):36-9. PubMed ID: 20137114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.
    Xu W; Miao KR; Hong M; Zhu DX; Fang C; Dong HJ; Wang DM; Cao X; Li JY
    Eur J Cancer; 2010 Aug; 46(12):2145-9. PubMed ID: 20627536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of p53 dysfunction on purine analogue cytotoxicity in chronic lymphocytic leukaemia.
    Pettitt AR; Sherrington PD; Cawley JC
    Br J Haematol; 1999 Sep; 106(4):1049-51. PubMed ID: 10520012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.